Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Bayer Aktiengesellschaft (BAYRY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
04:46pm, Tuesday, 13'th Jan 2026
Bayer Aktiengesellschaft (BAYRY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Bayer Accelerates Pharma Growth on High-Value Portfolio
02:15pm, Tuesday, 13'th Jan 2026
SAN FRANCISCO--(BUSINESS WIRE)--On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG today unveiled the strategic focus for its Pharmaceuticals Division in 2026. Ca
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it has partnered with actress and menopause advocate Gabrielle Union-Wade on the ‘Life Doesn't Stop for a Hot Flash' campaign, which speaks to
Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress
10:20am, Friday, 09'th Jan 2026
Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next-gen genetic medicines.
Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
02:30am, Thursday, 08'th Jan 2026
BERLIN & BOSTON--(BUSINESS WIRE)--Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic collaborat
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock
10:50am, Wednesday, 07'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Bayer sues COVID vaccine makers over mRNA technology
03:45pm, Tuesday, 06'th Jan 2026
Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology in manufacturing their vaccines, a
Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan's 44th Annual Healthcare Conference
12:54pm, Monday, 05'th Jan 2026
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will participate in the 44th J.P. Morgan Healthcare Conference 2026 taking place from January 12–15, 2026 in San Francisco. Stefan Oelrich, Member of the Board
BAYRY's 2025 Revival: Will the Momentum Continue in 2026?
09:12am, Wednesday, 31'st Dec 2025
BAYRY shares have risen 121.6% in a year as new FDA approvals, pipeline wins and litigation updates fuel a sharp turnaround.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Given Average Recommendation of “Buy” by Brokerages
01:15am, Sunday, 28'th Dec 2025
Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) have received an average recommendation of "Buy" from the six analysts that are presently covering the company, MarketBeat reports.
Bayer: Is This The Turning Point Investors Have Been Waiting For?
05:05am, Saturday, 13'th Dec 2025
Bayer Aktiengesellschaft remains deeply undervalued despite ongoing operational and litigation headwinds, supporting a bullish stance. Q3/25 results were weak, but technicals and intrinsic value calcu
Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
02:30am, Thursday, 04'th Dec 2025
BERLIN--(BUSINESS WIRE)--Bayer announced today initiation of a Phase IIa clinical trial with BAY 3401016, an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A
Bayer Stock Up as Government Backs Supreme Court Review in Roundup Case
01:46pm, Wednesday, 03'rd Dec 2025
Bayer shares jump after the U.S. Solicitor General backs a Supreme Court review of its Roundup case, adding momentum to its strong 2025 run.
RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints
01:00pm, Wednesday, 03'rd Dec 2025
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a global leader in radiology, today revealed results from the QUANTI Pediatric study, adding to the pharmacokinetic, safety and efficacy data of the investigati
Why Bayer Aktiengesellschaft (BAYRY) is a Top Momentum Stock for the Long-Term
10:50am, Wednesday, 03'rd Dec 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
